373 related articles for article (PubMed ID: 17294352)
1. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?
van der Horst IC; Voors AA; van Veldhuisen DJ
Clin Res Cardiol; 2007 Apr; 96(4):193-5. PubMed ID: 17294352
[No Abstract] [Full Text] [Related]
2. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists?
Hoppe UC
Clin Res Cardiol; 2007 Apr; 96(4):196-8. PubMed ID: 17294351
[No Abstract] [Full Text] [Related]
3. [Aldosterone antagonists for all patients with heart failure?].
Bauersachs J
MMW Fortschr Med; 2009 Apr; 151(15):33-5. PubMed ID: 19728679
[No Abstract] [Full Text] [Related]
4. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure].
Mundhenke M
Dtsch Med Wochenschr; 2006 Oct; 131(41):2297-8; author reply 2298. PubMed ID: 17036279
[No Abstract] [Full Text] [Related]
5. [Drug treatment for chronic heart failure with reduced ejection fraction].
Rickenbacher P
Ther Umsch; 2011 Feb; 68(2):71-9. PubMed ID: 21271537
[TBL] [Abstract][Full Text] [Related]
6. [Aldosterone receptor blockade after acute myocardial infarction with heart failure].
Bauersachs J; Ertl G
Med Klin (Munich); 2006 Jun; 101(6):458-66. PubMed ID: 16767569
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524
[No Abstract] [Full Text] [Related]
8. Neurohormonal intervention to reduce sudden cardiac death in heart failure: what is the optimal pharmacologic strategy?
Squire I
Heart Fail Rev; 2004 Oct; 9(4):337-45; discussion 347-51. PubMed ID: 15886979
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.
Zhang Z; Mahoney EM; Kolm P; Spertus J; Caro J; Willke R; Weintraub WS
Am J Cardiovasc Drugs; 2010; 10(1):55-63. PubMed ID: 20104935
[TBL] [Abstract][Full Text] [Related]
10. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
MMW Fortschr Med; 2005 Jul; 147(27-28):44. PubMed ID: 16041942
[No Abstract] [Full Text] [Related]
11. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers.
Aaronson K
Health News; 2003 May; 9(5):4. PubMed ID: 12739453
[No Abstract] [Full Text] [Related]
12. Heart failure and angiotensin converting enzyme inhibition: problems and perspectives.
Simko F; Simko J
Physiol Res; 1999; 48(1):1-8. PubMed ID: 10470860
[TBL] [Abstract][Full Text] [Related]
13. The role of the renin-angiotensin-aldosterone system in the management of heart failure.
Rodgers JE; Patterson JH
Pharmacotherapy; 2000 Nov; 20(11 Pt 2):368S-378S. PubMed ID: 11089708
[TBL] [Abstract][Full Text] [Related]
14. [Aldosterone and aldosterone antagonists. Eplerenone in cardiac insufficiency after myocardial infarction].
Heinzl S
Med Monatsschr Pharm; 2005 Mar; 28(3):76-9. PubMed ID: 15794365
[No Abstract] [Full Text] [Related]
15. Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
Weir RA; McMurray JJ; Puu M; Solomon SD; Olofsson B; Granger CB; Yusuf S; Michelson EL; Swedberg K; Pfeffer MA;
Eur J Heart Fail; 2008 Feb; 10(2):157-63. PubMed ID: 18242128
[TBL] [Abstract][Full Text] [Related]
16. [The role of aldosterone-antagonists in the treatment of congestive heart failure].
Fügedi K
Orv Hetil; 2005 Apr; 146(14):645-8. PubMed ID: 15889538
[TBL] [Abstract][Full Text] [Related]
17. Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?
Pitt B
Curr Heart Fail Rep; 2009 Jun; 6(2):112-6. PubMed ID: 19486595
[TBL] [Abstract][Full Text] [Related]
18. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
19. Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.
van Diepen S; Reynolds HR; Stebbins A; Lopes RD; Džavík V; Ruzyllo W; Geppert A; Widimsky P; Ohman EM; Parrillo JE; Dauerman HL; Baran DA; Hochman JS; Alexander JH
Crit Care Med; 2014 Feb; 42(2):281-8. PubMed ID: 23982033
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone antagonists: the most underutilized class of heart failure medications.
Guglin M; Awad KE; Polavaram L; Vankayala H
Am J Cardiovasc Drugs; 2007; 7(1):75-9. PubMed ID: 17355168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
